Celgene (CELG) ROE - Return on Equity

Current and historical Return on Equity (ROE) values for Celgene (CELG) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $112.846B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.